Skip to content
OpenCapital
Get started

Collegium Pharmaceutical, Inc. COLL Debt Repayments

Debt Repayments at other companies

Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc. INDV
$333M+8,225%
Avanos Medical logo
Avanos MedicalAVNS
$0-100%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$5M—
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$4.29M-7.1%
Organon logo
OrganonOGN
$32M-65.6%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$70M—

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0×0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfNotesPayable.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s debt repayments?
Collegium Pharmaceutical, Inc. (COLL) reported debt repayments of $7.25M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s debt repayments changed year-over-year?
Collegium Pharmaceutical, Inc.'s debt repayments decreased by 55.1% year-over-year, from $16.15M to $7.25M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s debt repayments?
Over 3 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s debt repayments has grown at a 133.4% compound annual growth rate (CAGR), from $50M to $635.56M.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.